{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:08:50Z","timestamp":1788793730824,"version":"build-2803163510"},"reference-count":24,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["S0008\u20102015\u20101"],"award-info":[{"award-number":["S0008\u20102015\u20101"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["261153"],"award-info":[{"award-number":["261153"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["accp1.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Extraparenchymal neurocysticercosis is the most severe form of cysticercosis, and response to treatment is suboptimal. We sought to determine how demographic and clinical characteristics and albendazole sulfoxide concentrations were related to cysticidal treatment response. We conducted a longitudinal study of 31 participants with extraparenchymal vesicular parasites who received the same treatment, albendazole 30 mg\/kg\/day for 10 days with dexamethasone 0.4 mg\/kg\/day for 13 days, followed by a prednisone taper. Response to treatment was determined by parasite volumes before and 6 months after treatment. Eight participants (25.8%) had a complete treatment response, 16 (51.6%) had a treatment response &gt; 50% but &lt; 100%, and 7 (22.6%) had a treatment response &lt; 50%. Complete treatment response was significantly associated with higher concentrations of albendazole sulfoxide (<jats:italic>P<\/jats:italic>\u00a0=\u00a0.032), younger age (<jats:italic>P<\/jats:italic>\u00a0=\u00a0.032), fewer cysts (<jats:italic>P<\/jats:italic>\u00a0=\u00a0.049) and lower pretreatment parasite volume (<jats:italic>P<\/jats:italic>\u00a0=\u00a0.037). Higher number of previous cysticidal treatment courses was associated with a noncomplete treatment response (<jats:italic>P<\/jats:italic>\u00a0=\u00a0.023). Although the large proportion of participants with less than a complete response emphasizes the need to develop more efficacious pharmacologic regimens, the association of albendazole sulfoxide concentrations with treatment response highlights the importance of optimizing existing therapeutic regimens. In addition, the association of treatment response with parasite volume emphasizes the importance of early diagnosis.<\/jats:p>","DOI":"10.1002\/jcph.1346","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T17:50:08Z","timestamp":1543254608000},"page":"548-556","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Factors Associated With Cysticidal Treatment Response in Extraparenchymal Neurocysticercosis"],"prefix":"10.1002","volume":"59","author":[{"given":"Rocio","family":"Osorio","sequence":"first","affiliation":[{"name":"Neuroinflammation Unit IIBM\u2010UNAM\/INNN\/Facultad de Medicina\u2010 UNAM  Ciudad de M\u00e9xico M\u00e9xico"},{"name":"Neurocysticercosis Clinic Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda  Ciudad de M\u00e9xico M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Carrillo\u2010Mezo","sequence":"additional","affiliation":[{"name":"Neuroradiology Department Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda  Ciudad de M\u00e9xico M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Romo","sequence":"additional","affiliation":[{"name":"School of Public Health Li Ka Shing Faculty of Medicine The University of Hong Kong  Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Toledo","sequence":"additional","affiliation":[{"name":"Neuroinflammation Unit IIBM\u2010UNAM\/INNN\/Facultad de Medicina\u2010 UNAM  Ciudad de M\u00e9xico M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Matus","sequence":"additional","affiliation":[{"name":"Neuroinflammation Unit IIBM\u2010UNAM\/INNN\/Facultad de Medicina\u2010 UNAM  Ciudad de M\u00e9xico M\u00e9xico"},{"name":"Neurocysticercosis Clinic Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda  Ciudad de M\u00e9xico M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iliana","family":"Gonz\u00e1lez\u2010Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Neuropsychopharmacology\u00a0Laboratory Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda  Ciudad de M\u00e9xico M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helgi","family":"Jung","sequence":"additional","affiliation":[{"name":"Neuropsychopharmacology\u00a0Laboratory Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda  Ciudad de M\u00e9xico M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Fleury","sequence":"additional","affiliation":[{"name":"Neuroinflammation Unit IIBM\u2010UNAM\/INNN\/Facultad de Medicina\u2010 UNAM  Ciudad de M\u00e9xico M\u00e9xico"},{"name":"Neurocysticercosis Clinic Instituto Nacional de Neurolog\u00eda y Neurocirug\u00eda  Ciudad de M\u00e9xico M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2018.1451328"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2018.08.011"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2016.01.013"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-017-9457-2_13"},{"key":"e_1_2_10_6_1","first-page":"406","article-title":"Human taeniasis\/cysticercosis: a potentially emerging parasitic disease in Europe","volume":"31","author":"Symeonidou I","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2106.141324"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005646"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1586\/eri.10.150"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002096"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2015.08.017"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24732"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-014-0345-2"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2015.05.007"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000195887.63124.dc"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.18-88751"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2018.1518133"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.1659"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2005.pto_172.x"},{"key":"e_1_2_10_20_1","first-page":"830","article-title":"Symptomatic human neurocysticercosis\u2014age, sex and exposure factors relating with disease heterogeneity","volume":"251","author":"Fleury A","year":"2004","journal-title":"J Neurol"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2009.07.007"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exppara.2014.12.002"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005875"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1179\/000349809X12459740922291"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2011.11.009"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcph.1346","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcph.1346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T18:50:39Z","timestamp":1694717439000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/jcph.1346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.1002\/jcph.1346"],"URL":"https:\/\/doi.org\/10.1002\/jcph.1346","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]},"assertion":[{"value":"2018-08-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}